A meta-analysis of chemokines in major depression

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 68, Issue , 2016, Pages 1-8

  Eyre, Harris A ^a,b,c   Air, Tracy ^a   Pradhan, Alyssa ^a   Johnston, James ^a   Lavretsky, Helen ^b   Stuart, Michael J ^a,d   Baune, Bernhard T ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JAMES COOK UNIVERSITY   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Chemokine; Cytokine; Depression; Diagnosis; Inflammation; Meta analysis; Mood disorder

Indexed keywords

INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; CHEMOKINE;

ARTHRITIS; ARTICLE; ASSAY; COMORBIDITY; CYTOMETRIC BEAD ASSAY; DSM-IV; EFFECT SIZE; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART DISEASE; HUMAN; MAJOR DEPRESSION; NEOPLASM; OBSERVATIONAL STUDY; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SYSTEMATIC REVIEW; META ANALYSIS; METABOLISM;

CHEMOKINES; DEPRESSIVE DISORDER, MAJOR; HUMANS;

EID: 84959159564     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2016.02.006     Document Type: Article

References (68)

1. Bai Y.M., Chiou W.F., Su T.P., Li C.T., Chen M.H. Pro-inflammatory cytokine associated with somatic and pain symptoms in depression. J. Affect. Disord. 2014, 155:28-34.
2. Banisadr G., Gosselin R.D., Mechighel P., Rostene W., Kitabgi P., Melik Parsadaniantz S. Constitutive neuronal expression of CCR2 chemokine receptor and its colocalization with neurotransmitters in normal rat brain: functional effect of MCP-1/CCL2 on calcium mobilization in primary cultured neurons. J. Comp. Neurol. 2005, 492:178-192.
3. Baune B.T., Smith E., Reppermund S., Air T., Samaras K., Lux O., Brodaty H., Sachdev P., Trollor J.N. Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: the prospective Sydney Memory and Aging Study. Psychoneuroendocrinology 2012, 37:1521-1530.
4. Baune B.T., Smith E., Reppermund S., Air T., Samaras K., Lux O., Brodaty H., Sachdev P., Trollor J.N. Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: the prospective Sydney Memory and Aging Study. Psychoneuroendocrinology 2012.
5. Brennand K.J., Simone A., Jou J., Gelboin-Burkhart C., Tran N., Sangar S., Li Y., Mu Y., Chen G., Yu D., McCarthy S., Sebat J., Gage F.H. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011, 473:221-225.
6. Carvalho L.A., Bergink V., Sumaski L., Wijkhuijs J., Hoogendijk W.J., Birkenhager T.K., Drexhage H.A. Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder. Transl. Psychiatry 2014, 4.
7. Cazareth J., Guyon A., Heurteaux C., Chabry J., Petit-Paitel A. Molecular and cellular neuroinflammatory status of mouse brain after systemic lipopolysaccharide challenge: importance of CCR2/CCL2 signaling. J. Neuroinflammation 2014, 11:132.
8. Cuthbert B.N. Translating intermediate phenotypes to psychopathology: the NIMH Research Domain Criteria. Psychophysiology 2014, 51:1205-1206.
9. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
10. Domenici E., Wille D.R., Tozzi F., Prokopenko I., Miller S., McKeown A., Brittain C., Rujescu D., Giegling I., Turck C.W., Holsboer F., Bullmore E.T., Middleton L., Merlo-Pich E., Alexander R.C., Muglia P. Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. PLoS One 2010, 5.
11. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., Lanctot K.L. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67:446-457.
12. Eller T., Vasar V., Shlik J., Maron E. Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2008, 32:445-450.
13. Eyre H., Baune B.T. Neuroplastic changes in depression: a role for the immune system. Psychoneuroendocrinology 2012, 37:1397-1416.
14. Eyre H., Air T., Proctor S., Rositano S., Baune B.T. A critical review of the efficacy of non-steroidal anti-inflammatory drugs in depression. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2015, 57:11-16. 10.1016/j.pnpbp.2014.10.003.
15. Giovannelli A., Limatola C., Ragozzino D., Mileo A.M., Ruggieri A., Ciotti M.T., Mercanti D., Santoni A., Eusebi F. CXC chemokines interleukin-8 (IL-8) and growth-related gene product alpha (GROalpha) modulate Purkinje neuron activity in mouse cerebellum. J. Neuroimmunol. 1998, 92:122-132.
16. Gordon R.J., McGregor A.L., Connor B. Chemokines direct neural progenitor cell migration following striatal cell loss. Mol. Cell. Neurosci. 2009, 41:219-232.
17. Grassi-Oliveira R., Brieztke E., Teixeira A., Pezzi J.C., Zanini M., Lopes R.P., Bauer M.E. Peripheral chemokine levels in women with recurrent major depression with suicidal ideation. Rev. Bras. Psiquiatr. 2012, 34:71-75.
18. Haapakoski R., Mathieu J., Ebmeier K.P., Alenius H., Kivimaki M. Cumulative meta-analysis of interleukins 6 and 1beta, tumour necrosis factor alpha and C-reactive protein in patients with major depressive disorder. Brain Behav. Immun. 2015, 49:206-215.
19. Hallberg L., Janelidze S., Engstrom G., Wisen A.G., Westrin A., Brundin L. Exercise-induced release of cytokines in patients with major depressive disorder. J. Affect. Disord. 2010, 126:262-267.
20. Hannestad J., DellaGioia N., Bloch M. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 2011, 36:2452-2459.
21. Haroon E., Raison C.L., Miller A.H. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 2012, 37:137-162.
22. Harrison E.L., Jaehne E.J., Jawahar M.C., Corrigan F., Baune B.T. Maternal separation modifies behavioural and neuroendocrine responses to stress in CCR7 deficient mice. Behav. Brain Res. 2014, 263:169-175.
23. Hartling L., Milne A., Hamm M.P., Vandermeer B., Ansari M., Tsertsvadze A., Dryden D.M. Testing the Newcastle Ottawa Scale showed low reliability between individual reviewers. J. Clin. Epidemiol. 2013, 66:982-993.
24. Higgins J.P., Flicker L. Lecithin for dementia and cognitive impairment. Cochrane Database Syst. Rev. 2003.
25. Hinojosa A.E., Garcia-Bueno B., Leza J.C., Madrigal J.L. CCL2/MCP-1 modulation of microglial activation and proliferation. J. Neuroinflammation 2011, 8:77.
26. Hocaoglu C., Kural B., Aliyazicioglu R., Deger O., Cengiz S. IL-1beta, IL-6, IL-8, IL-10, IFN-gamma, TNF-alpha and its relationship with lipid parameters in patients with major depression. Metab. Brain Dis. 2012, 27:425-430.
27. Holtzheimer P.E., Meeks T.W., Kelley M.E., Mufti M., Young R., McWhorter K., Vito N., Chismar R., Quinn S., Dey S., Byrd E.H., McDonald W.M. A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression. Int. J. Geriatr. Psychiatry 2008, 23:625-631.
28. Jaehne E.J., Baune B.T. Effects of chemokine receptor signalling on cognition-like, emotion-like and sociability behaviours of CCR6 and CCR7 knockout mice. Behav. Brain Res. 2014, 261:31-39.
29. Jonsdottir I.H., Hagg D.A., Glise K., Ekman R. Monocyte chemotactic protein-1 (MCP-1) and growth factors called into question as markers of prolonged psychosocial stress. PLoS One 2009, 4.
30. Kelland E.E., Gilmore W., Weiner L.P., Lund B.T. The dual role of CXCL8 in human CNS stem cell function: multipotent neural stem cell death and oligodendrocyte progenitor cell chemotaxis. Glia 2011, 59:1864-1878.
31. Lee K.S., Chung J.H., Lee K.H., Shin M.J., Oh B.H., Lee S.H., Hong C.H. Simultaneous measurement of 23 plasma cytokines in late-life depression. Neurol. Sci. 2009, 30:435-438.
32. Lehto S.M., Niskanen L., Herzig K.H., Tolmunen T., Huotari A., Viinamaki H., Koivumaa-Honkanen H., Honkalampi K., Ruotsalainen H., Hintikka J. Serum chemokine levels in major depressive disorder. Psychoneuroendocrinology 2010, 35:226-232.
33. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gotzsche P.C., Ioannidis J.P., Clarke M., Devereaux P.J., Kleijnen J., Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009, 339:b2700.
34. Licinio J. Translational psychiatry: leading the transition from the cesspool of devastation to a place where the grass is really greener. Transl. Psychiatry 2011, 1.
35. Lu S., Peng H., Wang L., Vasish S., Zhang Y., Gao W., Wu W., Liao M., Wang M., Tang H., Li W., Li W., Li Z., Zhou J., Zhang Z., Li L. Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: a cytokine antibody array analysis. Compr. Psychiatry 2013, 54:953-961.
36. Magalhaes P.V., Jansen K., Stertz L., Ferrari P., Pinheiro R.T., da Silva R.A., Kapczinski F. Peripheral eotaxin-1 (CCL11) levels and mood disorder diagnosis in a population-based sample of young adults. J. Psychiatr. Res. 2014, 48:13-15.
37. Marsland A.L., Sathanoori R., Muldoon M.F., Manuck S.B. Stimulated production of interleukin-8 covaries with psychosocial risk factors for inflammatory disease among middle-aged community volunteers. Brain Behav. Immun. 2007, 21:218-228.
38. McAfoose J., Baune B.T. Evidence for a cytokine model of cognitive function. Neurosci. Biobehav. Rev. 2009, 33:355-366.
39. Melik-Parsadaniantz S., Rostene W. Chemokines and neuromodulation. J. Neuroimmunol. 2008, 198:62-68.
40. Merendino R.A., Di Pasquale G., De Luca F., Di Pasquale L., Ferlazzo E., Martino G., Palumbo M.C., Morabito F., Gangemi S. Involvement of fractalkine and macrophage inflammatory protein-1 alpha in moderate-severe depression. Mediat. Inflamm. 2004, 13:205-207.
41. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009, 65:732-741.
42. Motivala S.J., Sarfatti A., Olmos L., Irwin M.R. Inflammatory markers and sleep disturbance in major depression. Psychosom. Med. 2005, 67:187-194.
43. Murphy P.M., Baggiolini M., Charo I.F., Hebert C.A., Horuk R., Matsushima K., Miller L.H., Oppenheim J.J., Power C.A. International Union of Pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 2000, 52:145-176.
44. Murray C.J., Vos T., Lozano R., Naghavi M., Flaxman A.D., Michaud C., Ezzati M., Shibuya K., Salomon J.A., Abdalla S., Aboyans V., Abraham J., Ackerman I., Aggarwal R., Ahn S.Y., Ali M.K., Alvarado M., Anderson H.R., Anderson L.M., Andrews K.G., Atkinson C., Baddour L.M., Bahalim A.N., Barker-Collo S., Barrero L.H., Bartels D.H., Basanez M.G., Baxter A., Bell M.L., Benjamin E.J., Bennett D., Bernabe E., Bhalla K., Bhandari B., Bikbov B., Bin Abdulhak A., Birbeck G., Black J.A., Blencowe H., Blore J.D., Blyth F., Bolliger I., Bonaventure A., Boufous S., Bourne R., Boussinesq M., Braithwaite T., Brayne C., Bridgett L., Brooker S., Brooks P., Brugha T.S., Bryan-Hancock C., Bucello C., Buchbinder R., Buckle G., Budke C.M., Burch M., Burney P., Burstein R., Calabria B., Campbell B., Canter C.E., Carabin H., Carapetis J., Carmona L., Cella C., Charlson F., Chen H., Cheng A.T., Chou D., Chugh S.S., Coffeng L.E., Colan S.D., Colquhoun S., Colson K.E., Condon J., Connor M.D., Cooper L.T., Corriere M., Cortinovis M., de Vaccaro K.C., Couser W., Cowie B.C., Criqui M.H., Cross M., Dabhadkar K.C., Dahiya M., Dahodwala N., Damsere-Derry J., Danaei G., Davis A., De Leo D., Degenhardt L., Dellavalle R., Delossantos A., Denenberg J., Derrett S., Des Jarlais D.C., Dharmaratne S.D., Dherani M., Diaz-Torne C., Dolk H., Dorsey E.R., Driscoll T., Duber H., Ebel B., Edmond K., Elbaz A., Ali S.E., Erskine H., Erwin P.J., Espindola P., Ewoigbokhan S.E., Farzadfar F., Feigin V., Felson D.T., Ferrari A., Ferri C.P., Fevre E.M., Finucane M.M., Flaxman S., Flood L., Foreman K., Forouzanfar M.H., Fowkes F.G., Fransen M., Freeman M.K., Gabbe B.J., Gabriel S.E., Gakidou E., Ganatra H.A., Garcia B., Gaspari F., Gillum R.F., Gmel G., Gonzalez-Medina D., Gosselin R., Grainger R., Grant B., Groeger J., Guillemin F., Gunnell D., Gupta R., Haagsma J., Hagan H., Halasa Y.A., Hall W., Haring D., Haro J.M., Harrison J.E., Havmoeller R., Hay R.J., Higashi H., Hill C., Hoen B., Hoffman H., Hotez P.J., Hoy D., Huang J.J., Ibeanusi S.E., Jacobsen K.H., James S.L., Jarvis D., Jasrasaria R., Jayaraman S., Johns N., Jonas J.B., Karthikeyan G., Kassebaum N., Kawakami N., Keren A., Khoo J.P., King C.H., Knowlton L.M., Kobusingye O., Koranteng A., Krishnamurthi R., Laden F., Lalloo R., Laslett L.L., Lathlean T., Leasher J.L., Lee Y.Y., Leigh J., Levinson D., Lim S.S., Limb E., Lin J.K., Lipnick M., Lipshultz S.E., Liu W., Loane M., Ohno S.L., Lyons R., Mabweijano J., MacIntyre M.F., Malekzadeh R., Mallinger L., Manivannan S., Marcenes W., March L., Margolis D.J., Marks G.B., Marks R., Matsumori A., Matzopoulos R., Mayosi B.M., McAnulty J.H., McDermott M.M., McGill N., McGrath J., Medina-Mora M.E., Meltzer M., Mensah G.A., Merriman T.R., Meyer A.C., Miglioli V., Miller M., Miller T.R., Mitchell P.B., Mock C., Mocumbi A.O., Moffitt T.E., Mokdad A.A., Monasta L., Montico M., Moradi-Lakeh M., Moran A., Morawska L., Mori R., Murdoch M.E., Mwaniki M.K., Naidoo K., Nair M.N., Naldi L., Narayan K.M., Nelson P.K., Nelson R.G., Nevitt M.C., Newton C.R., Nolte S., Norman P., Norman R., O'Donnell M., O'Hanlon S., Olives C., Omer S.B., Ortblad K., Osborne R., Ozgediz D., Page A., Pahari B., Pandian J.D., Rivero A.P., Patten S.B., Pearce N., Padilla R.P., Perez-Ruiz F., Perico N., Pesudovs K., Phillips D., Phillips M.R., Pierce K., Pion S., Polanczyk G.V., Polinder S., Pope C.A., Popova S., Porrini E., Pourmalek F., Prince M., Pullan R.L., Ramaiah K.D., Ranganathan D., Razavi H., Regan M., Rehm J.T., Rein D.B., Remuzzi G., Richardson K., Rivara F.P., Roberts T., Robinson C., De Leon F.R., Ronfani L., Room R., Rosenfeld L.C., Rushton L., Sacco R.L., Saha S., Sampson U., Sanchez-Riera L., Sanman E., Schwebel D.C., Scott J.G., Segui-Gomez M., Shahraz S., Shepard D.S., Shin H., Shivakoti R., Singh D., Singh G.M., Singh J.A., Singleton J., Sleet D.A., Sliwa K., Smith E., Smith J.L., Stapelberg N.J., Steer A., Steiner T., Stolk W.A., Stovner L.J., Sudfeld C., Syed S., Tamburlini G., Tavakkoli M., Taylor H.R., Taylor J.A., Taylor W.J., Thomas B., Thomson W.M., Thurston G.D., Tleyjeh I.M., Tonelli M., Towbin J.A., Truelsen T., Tsilimbaris M.K., Ubeda C., Undurraga E.A., van der Werf M.J., van Os J., Vavilala M.S., Venketasubramanian N., Wang M., Wang W., Watt K., Weatherall D.J., Weinstock M.A., Weintraub R., Weisskopf M.G., Weissman M.M., White R.A., Whiteford H., Wiebe N., Wiersma S.T., Wilkinson J.D., Williams H.C., Williams S.R., Witt E., Wolfe F., Woolf A.D., Wulf S., Yeh P.H., Zaidi A.K., Zheng Z.J., Zonies D., Lopez A.D., AlMazroa M.A., Memish Z.A. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2197-2223.
45. Nakao A. Temporal regulation of cytokines by the circadian clock. J. Immunol. Res. 2014, 2014:614529.
46. O'Brien S.M., Scully P., Fitzgerald P., Scott L.V., Dinan T.G. Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J. Psychiatr. Res. 2007, 41:326-331.
47. Piletz J.E., Halaris A., Iqbal O., Hoppensteadt D., Fareed J., Zhu H., Sinacore J., Devane C.L. Pro-inflammatory biomakers in depression: treatment with venlafaxine. World J. Biol. Psychiatry 2009, 10:313-323.
48. Podlipny J., Hess Z., Vrzalova J., Rosolova H., Beran J., Petrlova B. Lower serum levels of interleukin-6 in a population sample with symptoms of depression than in a population sample without symptoms of depression. Physiol. Res./Acad. Sci. Bohemoslov. 2010, 59:121-126.
49. Ransohoff R.M., Brown M.A. Innate immunity in the central nervous system. J. Clin. Invest. 2012, 122:1164-1171.
50. Reaux-Le Goazigo A., Van Steenwinckel J., Rostene W., Melik Parsadaniantz S. Current status of chemokines in the adult CNS. Prog. Neurobiol. 2013, 104:67-92.
51. Rostene W., Kitabgi P., Parsadaniantz S.M. Chemokines: a new class of neuromodulator?. Nat. Rev. Neurosci. 2007, 8:895-903.
52. Rethorst C.D., Toups M.S., Greer T.L., Nakonezny P.A., Carmody T.J., Grannemann B.D., Huebinger R.M., Barber R.C., Trivedi M.H. Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder. Mol. Psychiatry 2013, 18:1119-1124. 10.1038/mp.2012.125.
53. Rostene W., Dansereau M.A., Godefroy D., Van Steenwinckel J., Reaux-Le Goazigo A., Melik-Parsadaniantz S., Apartis E., Hunot S., Beaudet N., Sarret P. Neurochemokines: a menage a trois providing new insights on the functions of chemokines in the central nervous system. J. Neurochem. 2011, 118:680-694.
54. Rostene W., Guyon A., Kular L., Godefroy D., Barbieri F., Bajetto A., Banisadr G., Callewaere C., Conductier G., Rovere C., Melik-Parsadaniantz S., Florio T. Chemokines and chemokine receptors: new actors in neuroendocrine regulations. Front. Neuroendocrinol. 2011, 32:10-24.
55. Shen Y., Lu P., Wei L., Cai I., Hu X., Chen W. Fluoxetine treatment for major depression decreases the plasma levels of cytokines. Afr. J. Biotechnol. 2010, 9:7346-7351.
56. Simon N.M., McNamara K., Chow C.W., Maser R.S., Papakostas G.I., Pollack M.H., Nierenberg A.A., Fava M., Wong K.K. A detailed examination of cytokine abnormalities in Major Depressive Disorder. Eur. Neuropsychopharmacol. 2008, 18:230-233.
57. Song C., Lin A., Bonaccorso S., Heide C., Verkerk R., Kenis G., Bosmans E., Scharpe S., Whelan A., Cosyns P., de Jongh R., Maes M. The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. J. Affect. Disord. 1998, 49:211-219.
58. Stuart M.J., Baune B.T. Depression and type 2 diabetes: inflammatory mechanisms of a psychoneuroendocrine co-morbidity. Neurosci. Biobehav. Rev. 2012, 36:658-676.
59. Stuart M.J., Baune B.T. Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: a systematic review of biomarker studies. Neurosci. Biobehav. Rev. 2014, 42:93-115.
60. Stuart M.J., Singhal G., Baune B.T. Systematic review of the neurobiological relevance of chemokines to psychiatric disorders. Front. Cell. Neurosci. 2015, 9:357.
61. Suarez E.C., Krishnan R.R., Lewis J.G. The relation of severity of depressive symptoms to monocyte-associated proinflammatory cytokines and chemokines in apparently healthy men. Psychosom. Med. 2003, 65:362-368.
62. Suarez E.C., Lewis J.G., Krishnan R.R., Young K.H. Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women. Psychoneuroendocrinology 2004, 29:1119-1128.
63. Subileau E.A., Rezaie P., Davies H.A., Colyer F.M., Greenwood J., Male D.K., Romero I.A. Expression of chemokines and their receptors by human brain endothelium: implications for multiple sclerosis. J. Neuropathol. Exp. Neurol. 2009, 68:227-240.
64. Sutcigil L., Oktenli C., Musabak U., Bozkurt A., Cansever A., Uzun O., Sanisoglu S.Y., Yesilova Z., Ozmenler N., Ozsahin A., Sengul A. Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clin. Dev. Immunol. 2007, 2007:76396.
65. Taylor W.D., Aizenstein H.J., Alexopoulos G.S. The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol. Psychiatry 2013, 18:963-974.
66. Tran P.B., Banisadr G., Ren D., Chenn A., Miller R.J. Chemokine receptor expression by neural progenitor cells in neurogenic regions of mouse brain. J. Comp. Neurol. 2007, 500:1007-1033.
67. Weiss N., Deboux C., Chaverot N., Miller F., Baron-Van Evercooren A., Couraud P.O., Cazaubon S. IL8 and CXCL13 are potent chemokines for the recruitment of human neural precursor cells across brain endothelial cells. J. Neuroimmunol. 2010, 223:131-134.
68. Wong M.L., Dong C., Maestre-Mesa J., Licinio J. Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response. Mol. Psychiatry 2008, 13:800-812.